MétaCan
Menu
Back to cohort
Record W2808108864 · doi:10.22608/apo.2018279

Pediatric Retinal Diseases

2017· editorial· en· W2808108864 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueAsia-Pacific Journal of Ophthalmology · 2017
Typeeditorial
Languageen
FieldMedicine
TopicRetinopathy of Prematurity Studies
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsMedicineRetinopathy of prematurityOphthalmologyCoats' diseaseRetinalPediatric ophthalmologyRetinal detachmentRetinoblastomaAfliberceptPharmacotherapyStrabismusSurgeryBevacizumabChemotherapyInternal medicine

Abstract

fetched live from OpenAlex

Retinal disorders in children can be very different than those in adults, and there are a number of considerations that are unique to the management of pediatric retina patients. Although we have made significant advances in our understanding of pediatric retinal disease, there is much we are still learning about the physiology and management of these conditions. The use of anti-vascular endothelial growth factor (anti-VEGF) has revolutionized the management of eye diseases, especially retinal vascular conditions. And now with use in the treatment of retinopathy of prematurity (ROP), anti-VEGF agents may give us a viable option in treating the most aggressive forms of disease, for example, aggressive posterior ROP. In addition to advances in therapy, we have seen a number of technological advancements in ophthalmic imaging and surgery for children. The field of pediatric retinal diseases is evolving at an incredible pace with widefield imaging, optical coherence tomography angiography, small gauge vitrectomy, and endoscopic surgery. This special issue of the Asia-Pacific Journal of Ophthalmology is dedicated to the subject of pediatric retinal diseases. The review articles were prepared by international experts in the field with topics ranging from pharmacotherapy, ROP, hereditary retinal diseases, surgical approaches to pediatric retinal disease, pediatric uveitis, familial exudative vitreoretinopathy, and imaging. The fundamentals around pharmacotherapy for the treatment of ROP will be discussed along with the evolving management paradigm for the use of anti-VEGF in the management of pediatric retinal disorders beyond ROP. An update on the management of retinoblastoma, the most common primary intraocular malignancy in childhood, is presented. We have now moved from not just having the ability to save a child's life, but with intra-arterial chemotherapy we also have vision-saving therapies for even the most advanced cases. There have also been recent advances in genetic testing and gene therapy for certain pediatric retinal conditions, and we are provided with the latest insights in hereditary retinal diseases. Imaging to better evaluate children is burgeoning, and the use of the latest imaging technology and ultra-widefield imaging are improving the diagnosis and understanding of pediatric retinal disease. New surgical approaches have been introduced more routinely with the application of endoscopy in pediatric vitreoretinal surgery. Endoscopy has made some of the most difficult cases more possible and ultimately may provide better outcomes for some patients who may have been considered inoperable. This special issue of the Asia-Pacific Journal of Ophthalmology on pediatric retinal diseases provides a must needed resource for those who care for the pediatric retina patient. We also hope this will stimulate more interest among the next generation of retinal specialists into taking on the challenge of caring for this unique group of patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.011
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Meta-epidemiology (narrow), Research integrity
Consensus categoriesResearch integrity
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: Editorial
Teacher disagreement score0.149
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.011
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.001
Bibliometrics0.0010.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.322
Teacher spread0.303 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it